---
id: ABPA-allergic-bronchopulmonary-aspergillosis_129
category: radiology
tags: [ABPA, allergic-bronchopulmonary-aspergillosis, asthma, chest-radiology, CT, central-bronchiectasis, mucoid-impaction]
deck: Infectious Diseases
created: 2025-11-11
modified: 2025-11-11
---

## Allergic Bronchopulmonary Aspergillosis (ABPA) - Chest Radiology

**Q:** What is allergic bronchopulmonary aspergillosis (ABPA), what are its characteristic CT findings, and what are the diagnostic criteria?

**A:**

## DEFINITION

**Allergic Bronchopulmonary Aspergillosis (ABPA):**

**"Hypersensitivity reaction to *Aspergillus fumigatus* colonizing the airways, causing asthma exacerbation and central bronchiectasis"**

**Pathophysiology:**
- ***Aspergillus* colonizes bronchi** (does NOT invade tissue)
- **Type I (IgE) + Type III (IgG) hypersensitivity** reactions
- **Eosinophilic inflammation** → bronchiectasis, mucus plugging
- **Chronic airway damage** → irreversible bronchiectasis

**Key Point:** **ABPA = hypersensitivity disease** (NOT infection - *Aspergillus* colonization, not invasion)

---

## PATIENT POPULATION

**Typical Patient:**
- **Asthma** (especially severe, poorly controlled) - 90%
- **Cystic fibrosis** (10-15% of CF patients develop ABPA)
- **Young adults** (20-40 years old)
- **Recurrent asthma exacerbations** despite therapy
- **Brown mucus plugs** in sputum (pathognomonic)

**Key Point:** **ABPA = poorly controlled asthma + recurrent exacerbations**

---

## CLASSIC CT FINDINGS

**Mnemonic: "ABPA FUNGUS"**

**A**irway dilation (central bronchiectasis) - **HALLMARK**
**B**ronchoceles (mucus-filled dilated bronchi)
**P**roximal bronchiectasis (central > peripheral) - **PATHOGNOMONIC**
**A**telectasis/collapse (mucus plugging)

**F**inger-in-glove sign (mucoid impaction)
**U**pper lobe predominance
**N**odules (centrilobular)
**G**round-glass opacities (eosinophilic infiltrates)
**U**nusual mucus (high-attenuation mucus - HAM)
**S**ignet ring sign (dilated bronchus > adjacent artery)

---

### **1. CENTRAL BRONCHIECTASIS (Hallmark Finding):**

**Definition:** **Bronchiectasis involving proximal (central) airways while sparing peripheral airways**

**CT Appearance:**
- **Dilated bronchi in inner 2/3 of lung**
- **Peripheral airways normal** (spared)
- **Signet ring sign:** Dilated bronchus adjacent to pulmonary artery (bronchus:artery ratio >1:1)
- **Cylindrical, varicose, or cystic** bronchiectasis

**Key Point:** **Central bronchiectasis with peripheral sparing = PATHOGNOMONIC for ABPA**

---

### **2. MUCOID IMPACTION:**

**"Finger-in-Glove Sign":**
- **Branching tubular/V-shaped opacities**
- **Mucus-filled dilated bronchi** with occlusion of distal end
- **High-attenuation mucus (HAM):** Mucus denser than paravertebral muscle (unique to ABPA)
- **"Toothpaste shadows"** on chest X-ray

**Key Point:** **Finger-in-glove sign = mucoid impaction** (pathognomonic for ABPA)

---

### **3. HIGH-ATTENUATION MUCUS (HAM):**

**Definition:** **Mucus plugs denser than paravertebral muscle on CT** (>70 Hounsfield units)

**Significance:**
- **Highly specific for ABPA** (seen in 30-50% of cases)
- Contains **iron, calcium, manganese** from fungal elements
- **Distinguishes ABPA from other causes of bronchiectasis**

**Key Point:** **High-density mucus on CT = ABPA** (iron/calcium from fungi)

---

### **4. OTHER FINDINGS:**

| **Finding** | **Description** | **Frequency** |
|-------------|-----------------|---------------|
| **Centrilobular nodules** | Tree-in-bud pattern (mucus/eosinophils) | 50-70% |
| **Consolidation** | Eosinophilic infiltrates | 30-50% |
| **Mosaic attenuation** | Air trapping (small airway disease) | 40-60% |
| **Upper lobe predominance** | Central bronchiectasis favors upper lobes | 60-70% |
| **Atelectasis** | Lobar collapse from mucus plugging | 20-30% |
| **Cavitation** | End-stage fibrosis with cystic bronchiectasis | Rare (late) |

**Key Point:** **Central bronchiectasis + high-attenuation mucus + centrilobular nodules = ABPA**

---

## DIAGNOSTIC CRITERIA (ISHAM 2013)

**Mnemonic: "ASTHMA-ABG"**

### **Predisposing Conditions:**
- **A**sthma (or cystic fibrosis)

### **Obligatory Criteria (ALL Required):**
- **S**erum total IgE **>1000 IU/mL** (without ABPA exacerbation) OR **>500 IU/mL** (with other criteria)
- **T**ype I hypersensitivity (positive skin test or *Aspergillus* IgE)
- **H**igh *Aspergillus*-specific IgG (precipitins or elevated IgG)
- **M**ucoid impaction OR central bronchiectasis on imaging
- **A**-specificity ruled out (other causes excluded)

### **Additional Supportive Criteria:**
- **A**-specific IgE (*Aspergillus*-specific IgE elevated)
- **B**lood eosinophilia (>500 cells/μL)
- **G**olden-brown mucus plugs in sputum

**Key Point:** **ABPA diagnosis = asthma + IgE >1000 + *Aspergillus* serology + central bronchiectasis**

---

## SEROLOGIC TESTING

**Required Tests:**
1. **Total IgE:** >1000 IU/mL (OR >500 with other criteria)
2. ***Aspergillus*-specific IgE:** Elevated (Type I hypersensitivity)
3. ***Aspergillus*-specific IgG:** Elevated (precipitins - Type III hypersensitivity)
4. **Eosinophil count:** >500 cells/μL (supportive)

**Key Point:** **Total IgE >1000 + *Aspergillus* IgE/IgG elevated = ABPA**

---

## STAGES OF ABPA

| **Stage** | **Name** | **Features** |
|-----------|----------|--------------|
| **I** | Acute | Asthma exacerbation, infiltrates, eosinophilia, IgE >1000 |
| **II** | Remission | Asymptomatic, IgE declines |
| **III** | Exacerbation | Recurrent symptoms, IgE rises |
| **IV** | Corticosteroid-dependent | Requires chronic steroids |
| **V** | Fibrotic | Irreversible fibrosis, cavitation, honeycombing |

**Key Point:** **ABPA is relapsing-remitting disease** (monitor IgE levels for exacerbations)

---

## DIFFERENTIAL DIAGNOSIS OF CENTRAL BRONCHIECTASIS

**Mnemonic: "CENTRAL"**

**C**hronic aspiration (elderly, dysphagia)
**E**osinophilic granulomatosis with polyangiitis (Churg-Strauss)
**N**TM infection (especially *M. avium complex*)
**T**raumatic (post-intubation stenosis)
**R**adiation-induced
**A**BPA - **MOST SPECIFIC**
**L**ymphoma (post-obstructive bronchiectasis)

**Key Point:** **Central bronchiectasis + asthma + elevated IgE = ABPA**

---

## TREATMENT

### **Acute Exacerbation:**

1. **Oral corticosteroids** (prednisone 0.5-1 mg/kg/day x 2 weeks, then taper)
   - **Goal:** Suppress inflammation, ↓ IgE
2. **Antifungal therapy** (controversial - adjunctive)
   - **Itraconazole** 200mg BID x 4-6 months
   - **OR voriconazole** (alternative)
   - **Reduces fungal burden** → ↓ antigenic stimulus
3. **Aggressive pulmonary toilet** (chest physiotherapy, mucolytics)
4. **Optimize asthma control** (inhaled steroids, bronchodilators)

**Key Point:** **ABPA treatment = corticosteroids (suppress inflammation) + itraconazole (↓ fungal load)**

---

### **Maintenance Therapy:**

- **Inhaled corticosteroids** (high-dose)
- **Itraconazole** 200mg daily (if recurrent exacerbations)
- **Monitor IgE levels** every 2-3 months (↑ IgE = exacerbation)
- **Serial chest CT** (assess progression of bronchiectasis)

**Key Point:** **Monitor IgE levels** (rising IgE = early exacerbation requiring steroid boost)

---

## COMPLICATIONS

**Chronic ABPA:**
- **Irreversible bronchiectasis** (central airways)
- **Pulmonary fibrosis** (end-stage, Stage V)
- **Chronic respiratory failure**
- **Recurrent infections** (in bronchiectatic airways)
- **Aspergilloma formation** (in cystic bronchiectatic cavities)

**Key Point:** **Untreated ABPA → progressive bronchiectasis → fibrosis**

---

**Clinical Pearls:**
- **ABPA = hypersensitivity to *Aspergillus* colonization** (NOT invasive infection)
- **Classic patient: Poorly controlled asthma with recurrent exacerbations**
- **Pathognomonic CT finding: Central bronchiectasis with peripheral sparing**
- **Finger-in-glove sign = mucoid impaction** (branching tubular opacities)
- **High-attenuation mucus (HAM) = highly specific** (denser than muscle)
- **Diagnostic criteria: Asthma + IgE >1000 + *Aspergillus* serology + central bronchiectasis**
- **Treatment: Corticosteroids (suppress inflammation) + itraconazole (reduce fungal load)**
- **Monitor IgE levels** (rising IgE = exacerbation)
- **ABPA stages: Acute → Remission → Exacerbation → Steroid-dependent → Fibrotic**
- **Complications: Irreversible bronchiectasis, fibrosis, aspergilloma formation**
- **Brown mucus plugs in sputum = pathognomonic**
- **10-15% of CF patients develop ABPA**

**Media:**

**Image 1 - Central Bronchiectasis (Hallmark of ABPA):**
![ABPA Central Bronchiectasis](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e895/4129294/9bb839252e8c/jcdr-8-RC05-g001.jpg)

*Axial HRCT chest showing bilateral central bronchiectasis with mucoceles (mucus-filled dilated bronchi). Note the signet ring sign (dilated bronchus > adjacent pulmonary artery) and sparing of peripheral airways - pathognomonic for ABPA.*

**Image 2 - High-Attenuation Mucus (HAM):**
![High-Attenuation Mucus](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e895/4129294/f96d017aa083/jcdr-8-RC05-g004.jpg)

*Axial HRCT chest showing high-attenuation mucus (HAM) in a dilated bronchus with adjacent collapsed segment of right middle lobe. The mucus appears denser than paravertebral muscle - highly specific for ABPA (contains iron/calcium from fungal elements).*

**Image 3 - Centrilobular Nodules + Central Bronchiectasis:**
![ABPA with Nodules](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e895/4129294/8493fbbe45f2/jcdr-8-RC05-g003.jpg)

*Coronal HRCT showing bilateral central bronchiectasis with mucoceles and centrilobular nodules in right upper lobe. The combination of central bronchiectasis + centrilobular nodules + mucoid impaction strongly favors ABPA diagnosis.*

**Source:** PMC4129294 - "Allergic Bronchopulmonary Aspergillosis (ABPA)-The HRCT Chest Imaging Scenario" (J Clin Diagn Res 2014)
**License:** Open Access (PMC)
**Direct URL:** https://pmc.ncbi.nlm.nih.gov/articles/PMC4129294/

**Additional Resources:**
- PMC3249935 - "Pictorial essay: Allergic bronchopulmonary aspergillosis"
- PMC2999313 - "High attenuation mucoid impaction in ABPA"
- ISHAM Working Group 2013 - ABPA diagnostic criteria

**Sources:** [PMC4129294], [PMC3249935], [ISHAM 2013 - ABPA criteria], [Radiopaedia - ABPA]
